EXTON, PA — SkinCure Oncology has launched its cutting-edge Image-Guided Superficial Radiation Therapy (Image-Guided SRT) in Chester County, offering a noninvasive alternative for treating nonmelanoma skin cancers. This innovative therapy is now available at Center City Dermatology located at 760 W. Lincoln Hwy. in Exton, marking the first time residents in the county can access this GentleCure™ experience.
Image-Guided SRT is a breakthrough in dermatological care, utilizing ultrasound imaging to precisely target and treat cancerous cells on the skin with low-level x-rays. This method stands out for its efficacy and safety, boasting a 99.3 percent cure rate for early-stage nonmelanoma cancers. Unlike traditional Mohs surgery, this therapy avoids common surgical side effects and is noted for its superior recurrence prevention.
Dr. Stephen D. Hess, M.D., Ph.D., of Center City Dermatology, emphasized the critical need for awareness of treatment options among the expected 4,800 individuals in Chester County who will face a nonmelanoma skin cancer diagnosis this year. “Image-Guided SRT, the most exciting technological innovation in dermatology today, is the new standard of care for early stage nonmelanoma skin cancer. We call it the GentleCure experience, and we are proud to be the first in Chester County to offer it,” Dr. Hess stated.
Kerwin Brandt, CEO of SkinCure Oncology, expressed enthusiasm about the partnership with Center City Dermatology. “We at SkinCure Oncology are delighted to partner with Center City Dermatology to offer this highly effective, noninvasive treatment option for their patients. Patients everywhere should have the choice of curing their nonmelanoma skin cancer without surgery.”
This partnership signals a significant advancement in local healthcare, providing Chester County residents with access to one of the most advanced nonsurgical skin cancer treatments available today.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.